1. Home
  2. ZLAB vs PTON Comparison

ZLAB vs PTON Comparison

Compare ZLAB & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • PTON
  • Stock Information
  • Founded
  • ZLAB 2013
  • PTON 2012
  • Country
  • ZLAB China
  • PTON United States
  • Employees
  • ZLAB N/A
  • PTON N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • PTON Recreational Games/Products/Toys
  • Sector
  • ZLAB Health Care
  • PTON Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • PTON Nasdaq
  • Market Cap
  • ZLAB 3.2B
  • PTON 3.2B
  • IPO Year
  • ZLAB 2017
  • PTON 2019
  • Fundamental
  • Price
  • ZLAB $26.35
  • PTON $7.78
  • Analyst Decision
  • ZLAB Buy
  • PTON Buy
  • Analyst Count
  • ZLAB 6
  • PTON 15
  • Target Price
  • ZLAB $57.22
  • PTON $9.13
  • AVG Volume (30 Days)
  • ZLAB 613.7K
  • PTON 15.1M
  • Earning Date
  • ZLAB 11-06-2025
  • PTON 11-06-2025
  • Dividend Yield
  • ZLAB N/A
  • PTON N/A
  • EPS Growth
  • ZLAB N/A
  • PTON N/A
  • EPS
  • ZLAB N/A
  • PTON N/A
  • Revenue
  • ZLAB $427,799,000.00
  • PTON $2,490,800,000.00
  • Revenue This Year
  • ZLAB $41.80
  • PTON $0.49
  • Revenue Next Year
  • ZLAB $49.93
  • PTON $1.72
  • P/E Ratio
  • ZLAB N/A
  • PTON N/A
  • Revenue Growth
  • ZLAB 32.56
  • PTON N/A
  • 52 Week Low
  • ZLAB $23.82
  • PTON $4.63
  • 52 Week High
  • ZLAB $44.34
  • PTON $10.90
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 30.35
  • PTON 50.04
  • Support Level
  • ZLAB $26.07
  • PTON $7.44
  • Resistance Level
  • ZLAB $29.77
  • PTON $7.97
  • Average True Range (ATR)
  • ZLAB 1.21
  • PTON 0.40
  • MACD
  • ZLAB -0.41
  • PTON 0.01
  • Stochastic Oscillator
  • ZLAB 3.54
  • PTON 66.80

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: